-
Je něco špatně v tomto záznamu ?
Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters
H. Kaci, S. Bodnárová, E. Fliszár-Nyúl, B. Lemli, H. Pelantová, K. Valentová, É. Bakos, C. Özvegy-Laczka, M. Poór
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- cytochrom P-450 CYP3A * metabolismus MeSH
- cytochrom P450 CYP2C19 metabolismus MeSH
- cytochrom P450 CYP2C9 metabolismus MeSH
- flavonoidy farmakologie MeSH
- glukuronidy MeSH
- lidé MeSH
- lidský sérový albumin metabolismus MeSH
- luteolin farmakologie MeSH
- přenašeče organických aniontů * metabolismus MeSH
- sírany metabolismus MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Luteolin and naringenin are flavonoids found in various foods/beverages and present in certain dietary supplements. After a high intake of these flavonoids, their sulfate and glucuronide conjugates reach micromolar concentrations in the bloodstream. Some pharmacokinetic interactions of luteolin and naringenin have been investigated in previous studies; however, only limited data are available in regard to their metabolites. In this study, we aimed to investigate the interactions of the sulfate and glucuronic acid conjugates of luteolin and naringenin with human serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. Our main findings are as follows: (1) Sulfate conjugates formed more stable complexes with albumin than the parent flavonoids. (2) Luteolin and naringenin conjugates showed no or only weak inhibitory action on the CYP enzymes examined. (3) Certain conjugates of luteolin and naringenin are potent inhibitors of OATP1B1 and/or OATP2B1 enzymes. (4) Conjugated metabolites of luteolin and naringenin may play an important role in the pharmacokinetic interactions of these flavonoids.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032003
- 003
- CZ-PrNML
- 005
- 20230131151651.0
- 007
- ta
- 008
- 230120s2023 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2022.114078 $2 doi
- 035 __
- $a (PubMed)36481402
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Kaci, Hana $u Drug Resistance Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Network, Magyar tudósok krt. 2., H-1117 Budapest, Hungary; Doctoral School of Biology, Institute of Biology, Eötvös Loránd University, Pázmány P. stny. 1/C, H-1117 Budapest, Hungary
- 245 10
- $a Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters / $c H. Kaci, S. Bodnárová, E. Fliszár-Nyúl, B. Lemli, H. Pelantová, K. Valentová, É. Bakos, C. Özvegy-Laczka, M. Poór
- 520 9_
- $a Luteolin and naringenin are flavonoids found in various foods/beverages and present in certain dietary supplements. After a high intake of these flavonoids, their sulfate and glucuronide conjugates reach micromolar concentrations in the bloodstream. Some pharmacokinetic interactions of luteolin and naringenin have been investigated in previous studies; however, only limited data are available in regard to their metabolites. In this study, we aimed to investigate the interactions of the sulfate and glucuronic acid conjugates of luteolin and naringenin with human serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. Our main findings are as follows: (1) Sulfate conjugates formed more stable complexes with albumin than the parent flavonoids. (2) Luteolin and naringenin conjugates showed no or only weak inhibitory action on the CYP enzymes examined. (3) Certain conjugates of luteolin and naringenin are potent inhibitors of OATP1B1 and/or OATP2B1 enzymes. (4) Conjugated metabolites of luteolin and naringenin may play an important role in the pharmacokinetic interactions of these flavonoids.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a cytochrom P-450 CYP3A $x metabolismus $7 D051544
- 650 _2
- $a glukuronidy $7 D020719
- 650 _2
- $a luteolin $x farmakologie $7 D047311
- 650 _2
- $a lidský sérový albumin $x metabolismus $7 D000075462
- 650 _2
- $a sírany $x metabolismus $7 D013431
- 650 12
- $a přenašeče organických aniontů $x metabolismus $7 D027361
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a flavonoidy $x farmakologie $7 D005419
- 650 _2
- $a cytochrom P450 CYP2C9 $x metabolismus $7 D065729
- 650 _2
- $a cytochrom P450 CYP2C19 $x metabolismus $7 D065731
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bodnárová, Slávka $u Department of Pharmacology, Faculty of Pharmacy, University of Pécs, Rókus u. 2, H-7624 Pécs, Hungary
- 700 1_
- $a Fliszár-Nyúl, Eszter $u Department of Pharmacology, Faculty of Pharmacy, University of Pécs, Rókus u. 2, H-7624 Pécs, Hungary; Food Biotechnology Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, H-7624 Pécs, Hungary
- 700 1_
- $a Lemli, Beáta $u Department of Pharmacology, Faculty of Pharmacy, University of Pécs, Rókus u. 2, H-7624 Pécs, Hungary; Green Chemistry Research Group, János Szentágothai Research Center, University of Pécs, Ifjúság útja 20, H-7624 Pécs, Hungary
- 700 1_
- $a Pelantová, Helena $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ-142 20 Prague, Czech Republic
- 700 1_
- $a Valentová, Kateřina $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ-142 20 Prague, Czech Republic
- 700 1_
- $a Bakos, Éva $u Drug Resistance Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Network, Magyar tudósok krt. 2., H-1117 Budapest, Hungary
- 700 1_
- $a Özvegy-Laczka, Csilla $u Drug Resistance Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Network, Magyar tudósok krt. 2., H-1117 Budapest, Hungary
- 700 1_
- $a Poór, Miklós $u Department of Pharmacology, Faculty of Pharmacy, University of Pécs, Rókus u. 2, H-7624 Pécs, Hungary; Food Biotechnology Research Group, János Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, H-7624 Pécs, Hungary. Electronic address: poor.miklos@pte.hu
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 157, č. - (2023), s. 114078
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36481402 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151646 $b ABA008
- 999 __
- $a ok $b bmc $g 1891029 $s 1183338
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 157 $c - $d 114078 $e 20221205 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20230120
